{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T17:19:58Z","timestamp":1649092798008},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1097\/jcn.0b013e3181cec6d1","type":"journal-article","created":{"date-parts":[[2013,7,4]],"date-time":"2013-07-04T02:55:04Z","timestamp":1372906504000},"page":"241-246","source":"Crossref","is-referenced-by-count":5,"title":["Cholesterol and Triglyceride Management"],"prefix":"10.1097","volume":"25","author":[{"given":"Lynne T.","family":"Braun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R4-13-20210128","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1001\/jama.1975.03240160024021","article-title":"Clofibrate and niacin in coronary heart disease.","volume":"231","year":"1975","journal-title":"JAMA"},{"key":"R5-13-20210128","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1056\/NEJMoa011090","article-title":"Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease.","volume":"245","author":"Brown","year":"2001","journal-title":"N Engl J Med"},{"key":"R6-13-20210128","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1001\/archinte.162.22.2597","article-title":"Diabetes, plasma insulin, and cardiovascular disease. Subgroup analysis from the Department of Veterans Affairs High-Density Lipoprotein Intervention Trial (VA-HIT).","volume":"162","author":"Rubins","year":"2002","journal-title":"Arch Intern Med"},{"key":"R7-13-20210128","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1001\/archinte.165.10.1154","article-title":"Bezafibrate for the secondary prevention of myocardial infarction in patients with metabolic syndrome.","volume":"165","author":"Tenenbaum","year":"2005","journal-title":"Arch Intern Med"},{"key":"R8-13-20210128","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1056\/NEJMoa040583","article-title":"Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 Investigators.","volume":"350","author":"Cannon","year":"2004","journal-title":"N Engl J Med"},{"key":"R10-13-20210128","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1161\/01.CIR.0000038419.53000.D6","article-title":"Low-density lipoprotein, non-high density lipoprotein, and apolipoprotein B as targets of lipid-lowering therapy.","volume":"106","author":"Grundy","year":"2002","journal-title":"Circulation"},{"key":"R11-13-20210128","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2337\/diaclin.26.1.3","article-title":"Clinical relevance of non-HDL cholesterol in patients with diabetes.","volume":"26","author":"Peters","year":"2008","journal-title":"Clin Diabetes"},{"key":"R12-13-20210128","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1161\/01.CIR.0000038496.57570.06","article-title":"Non-high-density lipoprotein cholesterol levels predict five-year outcome in the Bypass Angioplasty Revascularization Investigation (BARI).","volume":"106","author":"Bittner","year":"2002","journal-title":"Circulation"},{"key":"R13-13-20210128","doi-asserted-by":"crossref","first-page":"16","DOI":"10.2337\/diacare.26.1.16","article-title":"Non-HDL cholesterol as a predictor of cardiovascular disease in type 2 diabetes.","volume":"26","author":"Lu","year":"2003","journal-title":"Diabetes Care"},{"key":"R14-13-20210128","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1161\/01.CIR.0000133317.49796.0E","article-title":"Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.","volume":"110","author":"Grundy","year":"2004","journal-title":"Circulation"},{"key":"R15-13-20210128","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0140-6736(90)91656-U","article-title":"Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial.","volume":"336","author":"Ornish","year":"1990","journal-title":"Lancet"},{"key":"R16-13-20210128","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1001\/jama.280.23.2001","article-title":"Intensive lifestyle changes for reversal of coronary heart disease.","volume":"280","author":"Ornish","year":"1998","journal-title":"JAMA"},{"key":"R17-13-20210128","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/S0140-6736(94)92580-1","article-title":"Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease.","volume":"343","author":"de Lorgeril","year":"1994","journal-title":"Lancet"},{"key":"R18-13-20210128","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1161\/01.CIR.99.6.779","article-title":"Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction. Final report of the Lyon Diet Heart Study.","volume":"99","author":"de Lorgeril","year":"1999","journal-title":"Circulation"},{"key":"R19-13-20210128","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1056\/NEJMoa025039","article-title":"Adherence to a Mediterranean diet and survival in a Greek population.","volume":"348","author":"Trichopoulou","year":"2003","journal-title":"N Engl J Med"},{"key":"R20-13-20210128","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1093\/ajcn.81.2.380","article-title":"Direct comparison of a dietary portfolio of cholesterol-lowering foods with a statin in hypercholesterolemic participants.","volume":"81","author":"Jenkins","year":"2005","journal-title":"Am J Clin Nutr"},{"key":"R21-13-20210128","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1093\/ajcn.83.3.582","article-title":"Assessment of the longer-term effects of a dietary portfolio of cholesterol-lowering foods in hypercholesterolemia.","volume":"83","author":"Jenkins","year":"2006","journal-title":"Am J Clin Nutr"},{"key":"R23-13-20210128","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.atherosclerosissup.2008.05.007","article-title":"Novel aspects of postprandial lipemia in relation to atherosclerosis.","volume":"9","author":"Alipour","year":"2008","journal-title":"Atheroscler Suppl"},{"key":"R24-13-20210128","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s11883-003-0033-y","article-title":"Postprandial lipemia and cardiovascular disease.","volume":"5","author":"Hyson","year":"2003","journal-title":"Curr Atheroscler Rep"},{"key":"R25-13-20210128","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.2337\/diacare.26.12.3303","article-title":"Contribution of visceral adiposity to the exaggerated postprandial lipemia of men with impaired glucose tolerance.","volume":"26","author":"Blackburn","year":"2003","journal-title":"Diabetes Care"},{"key":"R27-13-20210128","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ijcard.2007.04.172","article-title":"Postprandial lipemia: an under-recognized atherogenic factor in patients with diabetes mellitus.","volume":"126","author":"Pastromas","year":"2008","journal-title":"Int J Cardiol"},{"issue":"suppl A","key":"R28-13-20210128","first-page":"26A","article-title":"Dietary cholesterol, cholesterol absorption, postprandial lipemia and atherosclerosis.","volume":"10","author":"Huff","year":"2003","journal-title":"Can J Clin Pharmacol"},{"key":"R29-13-20210128","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1161\/01.CIR.102.6.670","article-title":"Remnant lipoproteins induce proatherothrombogenic molecules in endothelial cells through a redox-sensitive mechanism.","volume":"102","author":"Doi","year":"2000","journal-title":"Circulation"},{"key":"R30-13-20210128","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.atherosclerosis.2005.01.012","article-title":"Remnant lipoproteinemia is a risk factor for endothelial vasomotor dysfunction and coronary artery disease in metabolic syndrome.","volume":"181","author":"Nakamura","year":"2005","journal-title":"Atherosclerosis"},{"key":"R31-13-20210128","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1001\/jama.298.3.309","article-title":"Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women.","volume":"298","author":"Bansal","year":"2007","journal-title":"JAMA"},{"key":"R32-13-20210128","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1001\/archinte.161.11.1413","article-title":"Non-high-density lipoprotein cholesterol as a predictor of cardiovascular disease mortality.","volume":"161","author":"Cui","year":"2001","journal-title":"Arch Intern Med"}],"container-title":["Journal of Cardiovascular Nursing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/JCN.0b013e3181cec6d1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T01:43:23Z","timestamp":1620956603000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005082-201005000-00013"}},"subtitle":["\"If I Take My Medication, Can I Eat What I Want?\""],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/jcn.0b013e3181cec6d1","relation":{},"ISSN":["0889-4655"],"issn-type":[{"value":"0889-4655","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]}}}